We are live on ! Find out more
NI

Nextech Invest Portfolio holdings

AUM $1.42B
1-Year Est. Return 304.47%
This Fund
S&P 500
This Quarter Est. Return
-15.31%
1 Year Est. Return
+304.47%
3 Year Est. Return
+631.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$616M
AUM Growth
-$95.9M
Cap. Flow
+$63.4M
Cap. Flow %
10.28%
Top 10 Hldgs %
93.61%
Holding
15
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$65.8M

Top Sells

Rank Stock Value
1
SPRY icon
ARS Pharmaceuticals
SPRY
+$2.47M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$38.5B
$332M 53.94%
7,601,087
+1,304,347
+21% +$65.8M
TYRA icon
2
Tyra Biosciences
TYRA
$1.85B
$56.4M 9.15%
4,055,861
– –
ORIC icon
3
Oric Pharmaceuticals
ORIC
$1.17B
$42.7M 6.92%
5,285,714
– –
CRGX
4
DELISTED
CARGO Therapeutics
CRGX
$38.1M 6.18%
2,642,502
– –
ARVN icon
5
Arvinas
ARVN
$530M
$27M 4.38%
1,408,394
– –
MRSN
6
DELISTED
Mersana Therapeutics
MRSN
$17.3M 2.8%
482,690
– –
TNGX icon
7
Tango Therapeutics
TNGX
$4.21B
$17.1M 2.77%
5,533,980
– –
ZYME icon
8
Zymeworks
ZYME
$1.62B
$16.3M 2.65%
1,113,946
– –
RLAY icon
9
Relay Therapeutics
RLAY
$4B
$15.8M 2.57%
3,846,409
– –
CGEM icon
10
Cullinan Oncology
CGEM
$1.06B
$13.9M 2.25%
1,141,145
– –
ALMS
11
Alumis Inc
ALMS
$3.36B
$11.6M 1.88%
1,476,998
– –
SPRY icon
12
ARS Pharmaceuticals
SPRY
$579M
$9.88M 1.6%
936,729
-176,300
-16% -$2.47M
CNTX icon
13
Context Therapeutics
CNTX
$56.7M
$7.79M 1.26%
7,419,355
– –
SLN
14
Silence Therapeutics
SLN
$546M
$6.55M 1.06%
952,400
– –
BOLD
15
Boundless Bio
BOLD
$55.7M
$3.56M 0.58%
1,228,069
– –

Similar funds

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.43B AUM 9.81% 1-Year Est. Return
APCM
Alaska Permanent Capital Management Anchorage, Alaska $1.43B AUM 13.12% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Nextech Invest's Q4 2024 Portfolio in Review

As of Q4 2024, Nextech Invest held 15 positions worth $616M, down 13% from $712M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Nextech Invest deployed $63.4M of net new capital in Q4 2024, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was ARS Pharmaceuticals, an estimated $2.47M trimmed.

  • Nextech Invest added most to Revolution Medicines in Q4 2024, an estimated $65.8M increase.
  • Nextech Invest's biggest Q4 2024 reduction was ARS Pharmaceuticals, cutting an estimated $2.47M.
  • Nextech Invest's ten largest holdings make up 94% of its $616M portfolio in Q4 2024.
  • Nextech Invest opened 0 new positions and closed 0 in Q4 2024.
  • Nextech Invest's portfolio value fell 13% quarter-over-quarter to $616M.

Based on Nextech Invest's 13F filing for Q4 2024, filed 14 Feb 2025.